
Brazil · Veterinary startup
JA Saúde Animal is a Brazilian veterinary pharmaceutical company focused on the research, development, and production of innovative medications and solutions for animal health.
Funding reportedLast round: Private equity
JA Saúde Animal is a Brazilian veterinary pharmaceutical company focused on the research, development, and production of innovative medications and solutions for animal health.
The company emphasizes therapeutic efficacy, practicality, and cost-effectiveness. With a strong manufacturing and commercial structure, JA Saúde Animal has a qualified internal team and a commercial team active throughout Brazil. The company exports its products to various countries in Latin America and Africa, and it is expanding into other regions. JA Saúde Animal has been recognized in the *Financial Times* ranking of the 500 fastest-growing companies in the Americas and has won awards in the “Top List Rural” by Revista Rural. Its product offerings include effective and safe medications such as Ivermectina 1% J.A and Ferrodex B12, along with distribution and commercialization services for veterinary products, including those from Fabiani Saúde Animal, which it acquired in 2025. The primary market includes producers of large livestock and the veterinary industry, both nationally and internationally.
Funding, as reported
What they build
Known for
dairy cattleelectrolyte supplementsconsumersagronegocioanimal disease managementantimicrobial veterinary drugsanimal disease treatmentbrazilian veterinary industrydistributionanimal parasite controlmanufacturingeducational resources for veterinarianspharmaceutical developmentveterinary care productsswine treatmentsanimal health clinical testing
Built with from their website
Google MapsGoogle Tag ManagerAmazon CloudFrontWordPress.orgWOWFont AwesomeYouTubeViewport MetaMicrosoft Windows Server 2012Facebook SDK
Windows ServerLetroMicrosoft ExcelMicrosoft Hyper-V ServerOWL CarouselGoogle Font APIFortinetMicrosoft Exchange
Add your raise, your deck and your story, and put JA Saúde Animal in front of investors. Or tell us what we have wrong.